Literature DB >> 23426953

Intersubject variability of blood analysis reference values: assessment of age and locality influence by means of a linear discriminant analysis model.

João C M Barreira1, Roberto Costa, M Graça Pombo, Isabel C F R Ferreira.   

Abstract

Glycemic and lipidic profiles might be influenced by several factors. The influence of the age group in the most extensively evaluated lipidic and glycemic parameters is more or less well-accepted. To verify this empirical notion, 996 human subjects aged between 21 and 90 years from different localities were characterized according to age. To assess lipid profile, total cholesterol and cholesterol associated with lipoprotein fractions (low-density lipoprotein cholesterol and high-density lipoprotein cholesterol) and triglycerides were determined. Regarding glycemic profile, glucose, and glycated hemoglobin were measured. The majority of the population had values of lipidic parameters fit into the reference values, presenting low or moderate risk for developing cardiovascular disease. Blood glucose was often far above the desirable, but this can be devalued due to the HbA1c values, which were overwhelmingly located in the normal range. The categorization of data in different age groups did not allow defining statistically significant differences. Despite the discriminant linear model was presented, the results indicate that age group did not act as a strong discriminant factor. Somehow unexpectedly, the most significant differences were found among the different localities, which tended to show a similarity according with their latitude. Furthermore, there were no significant correlations in the parameters associated with lipidic profile, but there was a direct correlation between glucose levels and HbA1c (glycemic parameters).
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23426953      PMCID: PMC6807493          DOI: 10.1002/jcla.21590

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  4 in total

1.  Improvement in bedtime plasma glucose level serves as a predictor of long-term blood glucose control in patients with Type 2 diabetes: a study with monotherapy of 50/50 premixed insulin analogue three times daily injection.

Authors:  Masami Tanaka; Hitoshi Ishii
Journal:  J Diabetes Complications       Date:  2010-06-22       Impact factor: 2.852

Review 2.  ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Authors:  Alberico L Catapano; Zeljko Reiner; Guy De Backer; Ian Graham; Marja-Riitta Taskinen; Olov Wiklund; Stefan Agewall; Eduardo Alegria; M John Chapman; Paul Durrington; Serap Erdine; Julian Halcox; Richard Hobbs; John Kjekshus; Pasquale Perrone Filardi; Gabriele Riccardi; Robert F Storey; David Wood
Journal:  Atherosclerosis       Date:  2011-07       Impact factor: 5.162

3.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Authors:  R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

Review 4.  Dyslipidemia therapy update: the importance of full lipid profile assessment.

Authors:  I B A Menown; G Murtagh; V Maher; M T Cooney; I M Graham; G Tomkin
Journal:  Adv Ther       Date:  2009-07-27       Impact factor: 3.845

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.